• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染的诊断与治疗

Diagnosis and Treatment of Infection (CDI).

作者信息

Gerding Dale N, File Thomas M, McDonald L Clifford

机构信息

Edward Hines Jr VA Hospital, Hines, IL.

Loyola University Chicago Stritch School of Medicine, Chicago, IL.

出版信息

Infect Dis Clin Pract (Baltim Md). 2016 Jan;24(1):3-10. doi: 10.1097/IPC.0000000000000350.

DOI:10.1097/IPC.0000000000000350
PMID:29348706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5769958/
Abstract

Early and accurate diagnosis is essential for optimal treatment of individuals with infection (CDI) and for implementation of effective infection control procedures. The decision about which diagnostic test to use is an important one that should be based on test sensitivity, specificity, and predictive value. The challenges of CDI go beyond rapid identification and management of symptomatic patients. Asymptomatic carriage has long been suspected in transmission, but it may play a larger role than previously thought. Emerging information also shows that patients treated for CDI remain colonized for many weeks after symptom resolution. In fact, stool culture positivity increases during the first weeks following treatment completion. Treatments that reduce the duration and degree of asymptomatic shedding could have added benefit for reduced transmission.

摘要

早期准确诊断对于艰难梭菌感染(CDI)患者的最佳治疗以及实施有效的感染控制措施至关重要。决定使用哪种诊断测试是一项重要决策,应基于测试的敏感性、特异性和预测价值。CDI的挑战不仅在于对有症状患者的快速识别和管理。长期以来,无症状携带一直被怀疑在传播中起作用,但它可能比以前认为的作用更大。新出现的信息还表明,CDI患者在症状缓解后数周仍处于定植状态。事实上,在治疗完成后的头几周内,粪便培养阳性率会增加。减少无症状排菌持续时间和程度的治疗方法可能对减少传播有额外益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d2/5769958/ba15e3a9069e/nihms927849f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d2/5769958/ba15e3a9069e/nihms927849f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d2/5769958/ba15e3a9069e/nihms927849f1.jpg

相似文献

1
Diagnosis and Treatment of Infection (CDI).艰难梭菌感染的诊断与治疗
Infect Dis Clin Pract (Baltim Md). 2016 Jan;24(1):3-10. doi: 10.1097/IPC.0000000000000350.
2
Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.无症状但艰难梭菌毒素呈阳性?老年住院患者中产毒艰难梭菌携带者的患病率及危险因素
BMC Geriatr. 2016 Nov 15;16(1):185. doi: 10.1186/s12877-016-0358-3.
3
Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.对无症状携带者产毒艰难梭菌的全基因组测序:对传播中可能作用的深入了解。
J Hosp Infect. 2019 Jun;102(2):125-134. doi: 10.1016/j.jhin.2018.10.012. Epub 2018 Oct 22.
4
Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing.使用核酸检测对无症状和有症状住院患者进行艰难梭菌检测率的研究
Diagn Microbiol Infect Dis. 2017 Apr;87(4):365-370. doi: 10.1016/j.diagmicrobio.2016.12.014. Epub 2017 Jan 3.
5
Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.应用多位点可变串联重复分析基因分型技术来确定无症状携带者在艰难梭菌传播中的作用。
Clin Infect Dis. 2013 Oct;57(8):1094-102. doi: 10.1093/cid/cit475. Epub 2013 Jul 23.
6
Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents.无症状定植或感染的长期护理机构居民中艰难梭菌的传播。
Infect Control Hosp Epidemiol. 2018 Aug;39(8):909-916. doi: 10.1017/ice.2018.106. Epub 2018 May 31.
7
Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.艰难梭菌感染治疗期间和治疗后皮肤污染和艰难梭菌环境脱落的持续存在。
Infect Control Hosp Epidemiol. 2010 Jan;31(1):21-7. doi: 10.1086/649016.
8
Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy.利用拉曼光谱快速检测粪便中的艰难梭菌毒素。
J Surg Res. 2019 Dec;244:111-116. doi: 10.1016/j.jss.2019.06.039. Epub 2019 Jul 4.
9
Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.澳大利亚医院和社区中艰难梭菌核糖型的比较
J Clin Microbiol. 2016 Dec 28;55(1):216-225. doi: 10.1128/JCM.01779-16. Print 2017 Jan.
10
The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.将艰难梭菌感染检测从常规方法升级为基于分子的算法的临床和实验室影响:来自沙特阿拉伯东部省的一项观察性病例研究。 (注:Clostridioides difficile是艰难梭菌的新属名,原文中括号内的formerly Clostridium表示以前的梭菌属)
Clin Lab. 2019 Aug 1;65(8). doi: 10.7754/Clin.Lab.2019.181252.

引用本文的文献

1
Gut Microbiota-Gut Metabolites and Infection: Approaching Sustainable Solutions for Therapy.肠道微生物群-肠道代谢产物与感染:寻求可持续的治疗解决方案
Metabolites. 2024 Jan 22;14(1):74. doi: 10.3390/metabo14010074.
2
Gut microbiota and microbiota-based therapies for infection.肠道微生物群及基于微生物群的感染治疗方法。
Front Med (Lausanne). 2023 Jan 9;9:1093329. doi: 10.3389/fmed.2022.1093329. eCollection 2022.
3
Rapid-format recombinant antibody-based methods for the diagnosis of infection: Recent advances and perspectives.

本文引用的文献

1
Causes, Burden, and Prevention of Infection.感染的病因、负担及预防
Infect Dis Clin Pract (Baltim Md). 2015 May;23(6):281-288. doi: 10.1097/IPC.0000000000000331.
2
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.分子检测时代艰难梭菌感染的过度诊断
JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.
3
Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.
基于重组抗体的快速诊断感染方法:最新进展与展望
Front Microbiol. 2022 Nov 29;13:1043214. doi: 10.3389/fmicb.2022.1043214. eCollection 2022.
4
Antibiotic Resistances and Molecular Characteristics of in ICUs in a Teaching Hospital From Central South China.中国中部一所教学医院重症监护病房的抗生素耐药性及分子特征
Front Med (Lausanne). 2021 Dec 6;8:745383. doi: 10.3389/fmed.2021.745383. eCollection 2021.
5
Laboratory markers predictive of fulminant infection refractory to fluid resuscitation.预测对液体复苏难治的暴发性感染的实验室指标。
Infect Prev Pract. 2021 Feb 15;3(2):100127. doi: 10.1016/j.infpip.2021.100127. eCollection 2021 Jun.
6
Decreasing ICU-associated infection through fluoroquinolone restriction, the FIRST trial: a study protocol.通过氟喹诺酮类药物限制降低 ICU 相关性感染,FIRST 试验:研究方案。
BMJ Open. 2021 Jun 29;11(6):e046480. doi: 10.1136/bmjopen-2020-046480.
7
GABAergic but not Antidepressant Medications Increase Risk for Infection in a National Cohort of Veterans.在一个全国退伍军人队列中,γ-氨基丁酸能药物而非抗抑郁药物会增加感染风险。
Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa353. doi: 10.1093/ofid/ofaa353. eCollection 2020 Sep.
8
Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI.医生,我的患者患有艰难梭菌感染(CDI),应该继续接受抗生素治疗。存在复发性艰难梭菌感染的(未解决的)风险。
Rev Esp Quimioter. 2019 Sep;32 Suppl 2(Suppl 2):47-54.
9
Update in Infectious Diseases 2019.2019年传染病学最新进展
Rev Esp Quimioter. 2019 Sep;32 Suppl 2(Suppl 2):1-9.
10
Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.感染:药物敏感性和耐药机制的全球概述。
Biomed Res Int. 2018 Feb 21;2018:8414257. doi: 10.1155/2018/8414257. eCollection 2018.
非产毒艰难梭菌 M3 菌株孢子给药预防复发性艰难梭菌感染:一项随机临床试验。
JAMA. 2015 May 5;313(17):1719-27. doi: 10.1001/jama.2015.3725.
4
Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.粪便微生物移植治疗艰难梭菌感染:系统评价。
Ann Intern Med. 2015 May 5;162(9):630-8. doi: 10.7326/M14-2693.
5
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
6
The morbidity, mortality, and costs associated with Clostridium difficile infection.艰难梭菌感染相关的发病率、死亡率及成本。
Infect Dis Clin North Am. 2015 Mar;29(1):123-34. doi: 10.1016/j.idc.2014.11.003.
7
Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.口服、胶囊化、冷冻粪菌移植治疗复发性艰难梭菌感染。
JAMA. 2014 Nov 5;312(17):1772-8. doi: 10.1001/jama.2014.13875.
8
Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm.采用 PCR 与三步法诊断艰难梭菌感染患者的临床特征和结局。
Clin Microbiol Infect. 2014 Oct;20(10):1067-73. doi: 10.1111/1469-0691.12676. Epub 2014 Jul 12.
9
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.万古霉素、甲硝唑或托利美胺治疗艰难梭菌感染:两项多中心、随机、对照试验的结果。
Clin Infect Dis. 2014 Aug 1;59(3):345-54. doi: 10.1093/cid/ciu313. Epub 2014 May 5.
10
Prevalence and risk factors for asymptomatic Clostridium difficile carriage.无症状艰难梭菌携带的患病率及危险因素
Clin Infect Dis. 2014 Jul 15;59(2):216-22. doi: 10.1093/cid/ciu258. Epub 2014 Apr 21.